Inhaled nitric oxide therapy in adults: European expert recommendations

Peter Germann, Antonio Braschi, Giorgio Della Rocca, Anh Tuan Dinh-Xuan, Konrad Falke, Claes Frostell, Lars E. Gustafsson, Philippe Hervé, Philippe Jolliet, Udo Kaisers, Hector Litvan, Duncan J. Macrae, Marco Maggiorini, Nandor Marczin, Bernd Mueller, Didier Payen, Marco Ranucci, Dietmar Schranz, Rainer Zimmermann, Roman Ullrich

Research output: Contribution to journalArticlepeer-review


Background: Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care. Methods: This contribution assesses evidence for the use of iNO in this population as presented to a expert group jointly organised by the European Society of Intensive Care Medicine and the European Association of Cardiothoracic Anaesthesiologists. Conclusions: Expert recommendations on the use of iNO in adults were agreed on following presentation of the evidence at the expert meeting held in June 2004.

Original languageEnglish
Pages (from-to)1029-1041
Number of pages13
JournalIntensive Care Medicine
Issue number8
Publication statusPublished - Jul 2005


  • Acute lung injury
  • Acute respiratory distress syndrome
  • Cardiac surgery
  • Inhaled nitric oxide
  • Lung transplantation
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Inhaled nitric oxide therapy in adults: European expert recommendations'. Together they form a unique fingerprint.

Cite this